bcbsil glp-1 coverage GLP-1s and The Payer Predicament Ro launches GLP-1 insurance coverage

Cubillos J, Tse C, Chan VW, Perlas A

B., Zuccotti, G., & Fiorina, P

3 If initial therapy with metformin and lifestyle efforts are not adequate to achieve individualized glycemic targets, the guidelines recommend that patients should progress to dual therapy by adding either another oral agent, basal insulin, or an injectable GLP-1 receptor agonist

doi: 10.7717/peerj.17615 46 McMorrowHECohenABLorchCMHayesNWFlepsSWFrydmanJAet al

Archived from the original on 10 June 2023

Pierre-Louis: It really feels like, especially if youre using these drugs for weight loss, you really should be weighing the pros and cons and really be thinking through the long term, especially within the back of your head, that you might not actually be on these drugs forever